Introduction: Oral finasteride and topical minoxidil are longstanding androgenetic alopecia (AGA) treatments; topical finasteride is a more recent medicine. Few studies have compared their therapeutic effects in postmenopausal women.
Bamimore M. A. +5 more
core +1 more source
Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. [PDF]
Złotowska A +2 more
europepmc +1 more source
Diet-Induced Obesity Promotes Alopecia Through Oxidative Stress and Androgen Signalling in Female Mice. [PDF]
Tu YA +5 more
europepmc +1 more source
Introduction Finasteride, a 5α-reductase inhibitor, is used in the management of androgenetic alopecia and benign prostatic hyperplasia (BPH). There is growing attention to the post-finasteride syndrome, a constellation of adverse events associated with ...
Herzog P +9 more
core
Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications. [PDF]
Braccagni G, Branca C, Bortolato M.
europepmc +1 more source
Botulinum toxin A for the Treatment of Androgenetic Alopecia: A Review. [PDF]
Basch L, Carver C, Jacobs R.
europepmc +1 more source
Efficacy and Safety of Microneedling Combined With Mesotherapy for Androgenic Alopecia: A Retrospective Study Comparing Four Treatment Protocols. [PDF]
Behrangi E +4 more
europepmc +1 more source
Targeting Aromatase and 5-α-Reductase to Limit Dysfunctional Adipogenesis in Multiple Symmetric Lipomatosis. [PDF]
Milan G +15 more
europepmc +1 more source
Introduction Finasteride, a 5α-reductase inhibitor, is used in the management of androgenetic alopecia and benign prostatic hyperplasia (BPH). There is growing attention to the post-finasteride syndrome, a constellation of adverse events associated with ...
Chughtai B. +9 more
core
Pungenin Promotes Hair Growth in Mouse Models of Androgenic Alopecia Through Transcriptional Regulation of the PI3K/AKT/mTOR Axis. [PDF]
Zhai W +6 more
europepmc +1 more source

